Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 6:22 pm Purchase | 2022-12-31 | 13G | OVID THERAPEUTICS INC OVID | BIOTECHNOLOGY VALUE FUND L P | 6,851,051 9.700% | 220,000 (+3.32%) | Filing History |
| 2023-02-13 10:28 am Sale | 2022-12-31 | 13G | OVID THERAPEUTICS INC OVID | Stonepine Capital Management LLC | 0 0.000% | -4,006,185 (Position Closed) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | OVID THERAPEUTICS INC OVID | Rubric Capital Management LP | 6,828,065 9.690% | 6,828,065 (New Position) | Filing History |
| 2023-02-10 2:28 pm Purchase | 2022-12-31 | 13G | OVID THERAPEUTICS INC OVID | EcoR1 Capital, LLC | 6,117,400 8.700% | 35,200 (+0.58%) | Filing History |
| 2023-02-09 11:30 am Sale | 2022-12-30 | 13G | OVID THERAPEUTICS INC OVID | The Vanguard Group | 2,581,736 3.660% | -860,882 (-25.01%) | Filing History |
| 2023-02-03 11:50 am Sale | 2022-06-21 | 13G | OVID THERAPEUTICS INC OVID | TAKEDA PHARMACEUTICAL CO LTD TAK | 0 0.000% | -8,781,996 (Position Closed) | Filing History |
| 2023-02-03 11:48 am Purchase | 2022-07-01 | 13G | OVID THERAPEUTICS INC OVID | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,781,996 12.200% | 1,250,000 (+16.60%) | Filing History |
| 2022-02-14 5:29 pm Sale | 2021-12-31 | 13G | OVID THERAPEUTICS INC OVID | During Matthew | 3,103,932 4.500% | -916,862 (-22.80%) | Filing History |
| 2022-02-14 4:31 pm Purchase | 2021-12-31 | 13G | OVID THERAPEUTICS INC OVID | LEVIN JEREMY M | 6,554,770 9.400% | 462,500 (+7.59%) | Filing History |
| 2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | OVID THERAPEUTICS INC OVID | EcoR1 Capital, LLC | 6,082,200 8.900% | 6,082,200 (New Position) | Filing History |
| 2022-02-11 5:47 pm Purchase | 2021-12-31 | 13G | OVID THERAPEUTICS INC OVID | Stonepine Capital Management LLC | 4,006,185 5.900% | 506,185 (+14.46%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | OVID THERAPEUTICS INC OVID | The Vanguard Group | 3,442,618 5.060% | 3,442,618 (New Position) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | OVID THERAPEUTICS INC OVID | BlackRock Inc. BLK | 1,202,730 1.800% | -2,209,003 (-64.75%) | Filing History |
| 2021-04-29 4:48 pm Purchase | 2021-04-20 | 13G | OVID THERAPEUTICS INC OVID | Stonepine Capital Management LLC | 3,500,000 5.300% | 3,500,000 (New Position) | Filing History |
| 2021-04-15 4:11 pm Purchase | 2021-04-13 | 13G | OVID THERAPEUTICS INC OVID | BIOTECHNOLOGY VALUE FUND L P | 6,631,051 10.100% | 2,109,000 (+46.64%) | Filing History |